Cite
MLA Citation
John Stewart et al.. “409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO).” Journal for immunotherapy of cancer, vol. 8, n.d., p. A434. http://access.bl.uk/ark:/81055/vdc_100144718941.0x000004